Duato Joaquin
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Duato Joaquin. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| JNJ | CEO and Chairman of the Board | Sale | 125,824 | $179.21 | $22,548,919 | Aug 22, 2025 |
| JNJ | CEO and Chairman of the Board | Gift | 130,852 | — | — | Mar 18, 2025 |
| JNJ | CEO and Chairman of the Board | Tax Withholding | 8,386 | $156.71 | $1,314,170 | Feb 14, 2025 |
| JNJ | CEO and Chairman of the Board | Option Exercise | 126,369 | $100.06 | $12,644,482 | Feb 7, 2025 |
| JNJ | CEO and Chairman of the Board | Tax Withholding | 1,507 | $157.85 | $237,880 | Feb 13, 2024 |
| JNJ | CEO and Chairman of the Board | Option Exercise | 31,351 | — | — | Feb 12, 2024 |
| JNJ | CEO and Chairman of the Board | Tax Withholding | 98,662 | $156.76 | $15,466,255 | Feb 9, 2024 |
| JNJ | CEO and Chairman of the Board | Tax Withholding | 2,269 | $156.33 | $354,713 | Feb 8, 2024 |
| JNJ | CEO and Chairman of the Board | Disposition | 11,035 | — | — | Aug 23, 2023 |
| JNJ | CEO and Chairman of the Board | Tax Withholding | 13,599 | $162.01 | $2,203,174 | Feb 13, 2023 |
| JNJ | CEO and Chairman of the Board | Option Exercise | 5,220 | — | — | Feb 10, 2023 |
| JNJ | CEO and Chairman of the Board | Tax Withholding | 98,795 | $173.43 | $17,134,017 | Jan 17, 2023 |
| JNJ | CEO | Tax Withholding | 12,902 | $165.89 | $2,140,313 | Feb 15, 2022 |
| JNJ | CEO | Option Exercise | 5,424 | — | — | Feb 14, 2022 |
| JNJ | CEO | Option Exercise | 84,423 | $65.37 | $5,518,732 | Jan 14, 2022 |
| 0000004447 | Award / Grant | 2,332 | — | — | Mar 6, 2021 | |
| JNJ | Vice Chair, Exec Committee | Option Exercise | 27,738 | — | — | Feb 12, 2021 |
| 0000004447 | Purchase | 503 | $49.72 | $25,009 | Mar 6, 2020 | |
| JNJ | Vice Chair, Exec Committee | Option Exercise | 10,374 | — | — | Feb 13, 2020 |
| JNJ | Vice Chair, Exec Committee | Option Exercise | 22,624 | — | — | Feb 11, 2019 |
| JNJ | Vice Chair, Exec Committee | Option Exercise | 15,577 | $65.37 | $1,018,268 | Nov 7, 2018 |
| JNJ | Exec VP, WW Chair, Pharma | Tax Withholding | 14,486 | $129.51 | $1,876,082 | Feb 12, 2018 |
| JNJ | Exec VP, WW Chair, Pharma | Tax Withholding | 3,668 | $128.18 | $470,164 | Feb 9, 2018 |
| JNJ | Exec VP, WW Chair, Pharma | Option Exercise | 29,158 | $58.33 | $1,700,786 | Mar 3, 2017 |
| JNJ | Exec VP, WW Chair, Pharma | Tax Withholding | 16,175 | $115.67 | $1,870,962 | Feb 13, 2017 |
| JNJ | Exec VP, WW Chair, Pharma | Tax Withholding | 3,363 | $115.13 | $387,182 | Feb 10, 2017 |